Solara Active Pharma Sciences Approves Re-appointment of Internal and Cost Auditors for 2026-27
Solara Active Pharma Sciences Limited announced that its Board of Directors, during a meeting held on May 15, 2026, approved the re-appointment of both its Internal and Cost Auditors for the financial year 2026-27.The board approved the re-appointment of M/s. Grant Thornton Bharat LLP ('GT') as the company's Internal Auditors. Grant Thornton is noted as one of the leading professional service providing firms. The firm offers various business advisory services for both foreign and Indian companies, providing services across sectors and industries, including assurance, consulting, tax, risk, regulatory, finance, and digital and technology transformation.
Additionally, the board re-appointed Mr. M K Suryanarayanan as the Cost Auditors for the financial year 2026-27. Mr. Suryanarayanan is a Fellow member of The Institute and possesses over two decades of seasoned experience in Finance, Accounts, MIS, Costing, and Taxation. His professional background includes serving as a faculty member at The Institute of Cost Accountants of India and other management institutes. He has expertise in Cost Accounting Standards and Cost Audit for final students of CA and CMA, and has also served as a visiting faculty to various government and non-government entities. His experience scope further includes conducting special audits, desk reviews under the provisions of Indirect Tax for reputed multinationals, and handling assignments connected to Insurance and Transfer Pricing.
The details regarding the auditors, their terms, and the scope of their re-appointment are summarized below:
| Particulars | Internal Auditors (M/s. Grant Thornton Bharat LLP) | Cost Auditors (Mr. M K Suryanarayanan) |
|---|---|---|
| Reason for Appointment | Re-appointment of M/s. Grant Thornton Bharat LLP ('GT') | Re-appointment of Mr. K. Suryanarayanan |
| Date/Term of Appointment | May 15, 2026 (Financial Year 2026-27) | May 15, 2026 (Financial Year 2026-27) |
| Brief Profile | Leading professional service firm offering business advisory, assurance, consulting, tax, risk, regulatory, finance, and digital transformation services. | Fellow member with over two decades of experience in Finance, Accounts, MIS, Costing, and Taxation. Expertise includes handling Cost Accounting Standards and Cost Audit, and performing special audits and desk reviews under Indirect Tax. |
SOLARA Stock Price Movement
Shares of Solara Active Pharma Sciences Limited are surging to ₹577.8 as of 2:54 PM, capitalizing on a 13.81% gain of ₹70.10 in live trading. The stock demonstrates strong institutional interest, currently trading on a volume of 3.55 million shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.